Screener
BioLife Solutions BLFS CryoStor — Concentration risk (in percent)
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by BioLife Solutions in its filing.
Tagged under the XBRL concept us-gaap:ConcentrationRiskPercentage1.
The source filing: BioLife Solutions’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:22 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054355
FAQ
- What is BioLife Solutions's cryostor — concentration risk (in percent)?
- BioLife Solutions (BLFS) reported cryostor — concentration risk (in percent) of 84% in Q2 2026.
- How has BioLife Solutions's cryostor — concentration risk (in percent) changed year-over-year?
- BioLife Solutions's cryostor — concentration risk (in percent) increased by 5.0% year-over-year, from 80% to 84%.
- What is the long-term trend for BioLife Solutions's cryostor — concentration risk (in percent)?
- Over 2 years (2023 to 2025), BioLife Solutions's cryostor — concentration risk (in percent) has grown at a 19.4% compound annual growth rate (CAGR), from 174% to 248%.
- What does cryostor — concentration risk (in percent) mean?
- This metric measures the percentage of total segment revenue derived from a limited number of key customers or specific high-value contracts. A higher concentration indicates increased vulnerability to the loss of a major client or shifts in their procurement strategy. Monitoring this ratio helps assess the stability and diversification of the revenue stream within the biopreservation product line.
Ask your AI about BioLife Solutions's cryostor — concentration risk (in percent).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude